Could hepatitis c kidneys be safe for transplant?

NCT ID NCT04605679

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether kidneys from donors with hepatitis C (HCV) can be safely transplanted into people who do not have HCV and are waiting for a kidney. Researchers will track 31 recipients for one year to see how well the kidney and patient survive. The goal is to increase the number of available donor kidneys.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Kidney transplantation
What this could lead to
If successful, this could expand the donor pool for kidney transplants, reducing wait times for patients with kidney failure.
What could go wrong
This is a small, early-stage study with only 31 participants. There is a risk of HCV transmission or other complications, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Loma Linda University Health-Transplant Institute

    Loma Linda, California, 92354, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.